...
首页> 外文期刊>Emergency Care Journal >A simple tool to help ruling-out Covid-19 in the emergency department: derivation and validation of the LDH-CRP-Lymphocyte (LCL) score
【24h】

A simple tool to help ruling-out Covid-19 in the emergency department: derivation and validation of the LDH-CRP-Lymphocyte (LCL) score

机译:一个简单的工具,用于帮助急诊部门的判决Covid-19:衍生和验证LDH-CRP淋巴细胞(LCL)得分

获取原文

摘要

After the outbreak of the Covid-19 pandemic, cases of SARSCoV- 2 infections may gradually decrease in the next months. Given the reduced prevalence of the disease, Emergency Departments (ED) are starting to receive more and more non- Covid19 patients. Thus, a way to quickly discriminate ED patients with potential Covid-19 infection from non-Covid19 patients is needed in order to keep potentially contagious patients isolated while awaiting second-level testing. In this paper, we present the derivation and validation of a simple, practical, and cheap score that could be helpful to rule out Covid-19 among ED patients with suspicious symptoms (fever and/or dyspnoea). The LCL score was derived from a cohort of 335 patients coming to the ED of our hospital from March 16th to April 1st, 2020. It was then retrospectively validated in a similar cohort of 173 patients admitted to our ED during April. The score is based on blood values of lactate dehydrogenase, C-reactive protein, and lymphocyte count. The LCL score performed well both in the derivation and in the validation cohort, with an AUC respectively of 0.81 (95% CI: 0.77 – 0.86) and of 0.71 (95% CI: 0.63 – 0.78), given the difference in Covid- 19 prevalence between the two cohorts (57% vs 41% respectively). An LCL score equal to 0 had a negative predictive value of 0.92 in the derivation cohort and of 0.81 in the validation cohort, with a negative likelihood ratio respectively of 0.08 and 0.36 for Covid- 19 exclusion. This score could, therefore, constitute a useful tool to help physicians manage patients in the ED.
机译:在Covid-19大流行爆发后,SARSCOV-2感染的病例可能在未来几个月逐渐减少。鉴于疾病的患病率降低,急诊部门(ED)开始接受越来越多的非Covid19患者。因此,需要一种快速区分患有来自非Covid19患者的潜在Covid-19感染患者的患者的方法,以便在等待第二级测试时持续隔离潜在的传染病。在本文中,我们展示了一种简单,实用和廉价分数的推导和验证,可以有助于排除患有可疑症状(发烧和/或呼吸困难)的ED患者中的Covid-19。 LCL评分来自于2012年3月至4月1日至4月1日至4月1日从我们院内申请的335名患者队列。然后回顾性地验证了4月期间录取了我们ED的类似群组。分数基于乳酸脱氢酶,C反应蛋白和淋巴细胞计数的血值。 LCL评分在衍生和验证队列中表现良好,分别为0.81(95%CI:0.77-0.86)和0.71(95%CI:0.63 - 0.78),鉴于Covid-19两个队列之间的患病率(分别为57%vs 41%)。 LCL评分等于0的衍生队在衍生队队和验证队列中的负预测值为0.92,对于Covid-19排除,分别为0.08和0.36的负似然比。因此,该分数构成有用的工具,以帮助医生管理ED患者。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号